Plaque stabilisation in acute coronary syndromes: clinical considerations.
Timmis
Adam D
AD
Department of Cardiology, The London Chest Hospital, Bonner Road, London E2 9JX, UK. timmis@lch.demon.co.uk
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013577:Syndrome; D013917:Thrombin / Q000037:antagonists & inhibitors; D015912:Thrombolytic Therapy / Q000379:methods
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000893:Anti-Inflammatory Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D013917:Thrombin